It is estimated that less than one in ten people with dementia are eligible for treatment with Lecanemab or Leqembi, the ...

Researchers have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer's genesis and progression. The proteins were gathered from cerebrospinal ...

A once-a-day pill that targets the production of the stress hormone cortisol in the brain has the potential to be the “holy ...

Deprescription and the prevention of hospitalization should be priorities, rather than aggressive management, a family ...

European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

In the last two years, two drugs have been federally approved to slow the onset of Alzheimer's disease in its early stages, ...

Dementia is a condition that affects memory, thinking, and the ability to perform everyday tasks. As it progresses, it can ...

However, there are more biological drugs targeting beta-amyloid in research, and many other treatments in clinical ...

A new study by Monash University medicine safety experts found the use of gabapentinoids – medicines widely used to treat neuropathic pain – increased the risk of hip fractures, especially in older ...

Some dementia patients—and their caregivers—are seeking alternatives after traditional medications haven’t provided relief ..